NYSE:LLY

Eli Lilly Stock Insider Trading

Healthcare > Drug Manufacturers - General

Buy LLY

*Your capital is at risk

$1,116.11

-5.06 (-0.451%)

At Close: Aug 04, 2026

Eli Lilly Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -12.27. In total, the insiders bought 2.48B and sold 8.65M LLY shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-12.27
● Buy	2.48B shares
● Sell	8.65M shares
71% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence Nov 14, 2025 Analysis Breakdown: Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 16, 2026 Buy	Common Stock A-Award	Alvarez Ralph Director	Director	13 Value: $12.4K
Feb 19, 2026 Sell	Common Stock G-Gift	Dozier Eric EVP, Chief People Officer	Officer	481 Value: $0
Feb 17, 2026 Buy	Common Stock A-Award	Sulzberger Gabrielle Director	Director	5 Value: $5K
Feb 17, 2026 Buy	Common Stock A-Award	Fyrwald J Erik Director	Director	10 Value: $10K
Feb 17, 2026 Buy	Common Stock A-Award	Alvarez Ralph Director	Director	12 Value: $12.4K
Feb 17, 2026 Buy	Common Stock A-Award	Luciano Juan R Director	Director	15 Value: $15.9K
Feb 16, 2026 Buy	Restricted Stock Unit M-Exempt	Brown Adrienne S EVP, President Lly Imm	CEO / President	391 Value: $436.4K
Feb 16, 2026 Sell	Common Stock F-InKind	Brown Adrienne S EVP, President Lly Imm	CEO / President	170 Value: $176.8K
Feb 16, 2026 Buy	Common Stock M-Exempt	Zakrowski Donald A SVP, Finance, & Cao	Officer	184 Value: $205.4K
Feb 16, 2026 Sell	Common Stock F-InKind	Zakrowski Donald A SVP, Finance, & Cao	Officer	82 Value: $84.8K
Feb 16, 2026 Buy	Restricted Stock Unit M-Exempt	Zakrowski Donald A SVP, Finance, & Cao	Officer	184 Value: $205.4K
Feb 16, 2026 Buy	Common Stock M-Exempt	Montarce Lucas EVP & CFO	C-Suite Officer	368 Value: $410.7K
Feb 16, 2026 Sell	Common Stock F-InKind	Montarce Lucas EVP & CFO	C-Suite Officer	160 Value: $166.1K
Feb 16, 2026 Buy	Restricted Stock Unit M-Exempt	Montarce Lucas EVP & CFO	C-Suite Officer	368 Value: $410.7K
Feb 16, 2026 Buy	Common Stock M-Exempt	Custer Kenneth L. EVP & President, Card Met Hlth	CEO / President	207 Value: $231.0K
Feb 16, 2026 Sell	Common Stock F-InKind	Custer Kenneth L. EVP & President, Card Met Hlth	CEO / President	91 Value: $95.0K
Feb 16, 2026 Buy	Restricted Stock Unit M-Exempt	Custer Kenneth L. EVP & President, Card Met Hlth	CEO / President	207 Value: $231.0K
Feb 16, 2026 Buy	Common Stock M-Exempt	Brown Adrienne S EVP, President Lly Imm	CEO / President	391 Value: $436.4K
Feb 09, 2026 Buy	Common Stock A-Award	Rau Diogo EVP & Cido	Officer	4 599 Value: $4.80M
Feb 09, 2026 Buy	Common Stock A-Award	Zakrowski Donald A SVP, Finance, & Cao	Officer	584 Value: $609.9K
Feb 09, 2026 Buy	Common Stock A-Award	Yuffa Ilya EVP&pres, Lly Usa&global Capab	Officer	4 163 Value: $4.35M
Feb 09, 2026 Buy	Common Stock A-Award	Ricks David A President, Chair, And CEO	CEO / President	38 914 Value: $40.7M
Feb 09, 2026 Buy	Common Stock A-Award	Skovronsky Daniel EVP, Cs&po & Pres. Lrl	Officer	15 548 Value: $16.2M
Feb 09, 2026 Buy	Common Stock A-Award	Rau Diogo EVP & Cido	Officer	4 432 Value: $4.63M
Feb 09, 2026 Buy	Common Stock A-Award	Montarce Lucas EVP & CFO	C-Suite Officer	1 365 Value: $1.43M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ELI LILLY AND COMPANY

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...

Read Full Profile Here